Leonteq Securities’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.3K Buy
91
+23
+34% +$11.9K ﹤0.01% 778
2026
Q2
$36.8K Sell
68
-50
-42% -$28.2K ﹤0.01% 862
2026
Q1
$70K Sell
118
-67
-36% -$33.4K ﹤0.01% 800
2025
Q4
$90.1K Buy
185
+6
+3% +$2.79K ﹤0.01% 823
2025
Q3
$75K Sell
179
-232
-56% -$78K ﹤0.01% 808
2025
Q2
$118K Buy
411
+39
+10% +$11.7K ﹤0.01% 690
2025
Q1
$116K Sell
372
-19
-5% -$6.51K 0.01% 662
2024
Q4
$138K Sell
391
-67
-15% -$24.6K 0.01% 618
2024
Q3
$164K Buy
458
+147
+47% +$49.7K 0.01% 527
2024
Q2
$99.1K Buy
311
+24
+8% +$6.35K 0.01% 625
2024
Q1
$65.9K Buy
287
+187
+187% +$42.2K ﹤0.01% 722
2023
Q4
$22K Buy
+100
New +$23K ﹤0.01% 926
2023
Q3
– Sell
-100
Closed -$22.1K – 1296
2023
Q2
$22.1K Sell
100
-42
-30% -$9.3K ﹤0.01% 959
2023
Q1
$31.8K Buy
142
+42
+42% +$10.4K ﹤0.01% 881
2022
Q4
$27.8K Hold
100
– – ﹤0.01% 930
2022
Q3
$20.9K Hold
100
– – ﹤0.01% 952
2022
Q2
$23.6K Hold
100
– – ﹤0.01% 954
2022
Q1
$17.9K Hold
100
– – ﹤0.01% 1019
2021
Q4
$21.6K Sell
100
-135
-57% -$26.5K ﹤0.01% 1031
2021
Q3
$43.4K Buy
+235
New +$46.3K ﹤0.01% 871

Other funds holding UTHR

Leonteq Securities's UTHR Position: Q3 2026 in Review

Leonteq Securities increased its United Therapeutics (UTHR) stake by 34% in Q3 2026, buying an estimated $11.9K and bringing the position to 91 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Leonteq Securities first reported a position in UTHR in Q3 2021 and has held it in 20 quarters since. The position peaked at $164K in Q3 2024. 690 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Leonteq Securities held 91 shares of United Therapeutics worth $49.3K as of Q3 2026.
  • Leonteq Securities bought 23 United Therapeutics shares in Q3 2026, an estimated $11.9K.
  • United Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #778 holding.
  • Leonteq Securities first reported a position in United Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Leonteq Securities's United Therapeutics position peaked at $164K in Q3 2024.
  • 690 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.